Moderna Inc (MRNA)

Current ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Total current assets	US$ in thousands	10,325,000	10,799,000	10,599,000	12,122,000	13,431,000	14,297,000	13,563,000	16,350,000	16,071,000	13,425,000	10,969,000	11,703,000	6,298,000	3,577,210	2,796,740	1,249,940	1,128,800	1,094,470	1,097,420	1,140,830
Total current liabilities	US$ in thousands	3,015,000	4,385,000	3,123,000	3,499,000	4,923,000	6,807,000	6,812,000	9,238,000	9,128,000	9,957,000	8,840,000	8,441,000	4,389,000	1,473,560	161,647	134,582	143,115	147,842	161,987	159,159
Current ratio		3.42	2.46	3.39	3.46	2.73	2.10	1.99	1.77	1.76	1.35	1.24	1.39	1.43	2.43	17.30	9.29	7.89	7.40	6.77	7.17

December 31, 2023 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $10,325,000K ÷ $3,015,000K
= 3.42

The current ratio of Moderna Inc has exhibited fluctuations over the quarters analyzed. In Q4 2023, the current ratio stands at 3.42, indicating that the company has $3.42 in current assets for every $1 in current liabilities. This represents a strong liquidity position, suggesting that Moderna is well-equipped to cover its short-term obligations.

Comparing this with previous quarters, we observe a significant improvement from Q3 2023 (2.46) to Q4 2023, reflecting a better ability to meet short-term liabilities with current assets. Similarly, Q4 2023's current ratio is higher than in Q4 2022 (2.73), indicating enhanced liquidity management over the year.

The current trend suggests that Moderna has been efficiently managing its current assets and liabilities, resulting in improved liquidity ratios. Overall, the current ratio analysis indicates that Moderna Inc has strengthened its liquidity position, which is a positive signal for investors and stakeholders.